Ruxera 500 mg/50 ml and 100 mg/10 ml
Home
» Medicinal Products » Ruxera 500 mg/50 ml and 100 mg/10 ml
Rituximab 100 mg/10 ml
Rituximab 500 mg/50ml
Ruxera contains the active substance Rituximab, a “monoclonal antibody”. It sticks to the surface of a type of white blood cell called “B-Lymphocyte”. When rituximab sticks to the surface of this cell, the cell dies.
Ruxera is used for the treatment of:
- Non-Hodgkin’s Lymphoma.
- Chronic lymphocytic leukemia.
- Rheumatoid arthritis.
- Granulomatosis with polyangiitis or microscopic polyangiitis
Disclaimer: Items covered by valid patents not offered or supplied for commercial sale. Patent position should be verified by the buyer in the territory. :تنويه المستحضرات المشمولة ببراءات اختراع مسجلة، غير معروضة ولا يتم تزويدها من قبل الشركة. يجب التحقق من صحة وتسجيل براءة الاختراع من قبل المشتري في بلده